Real-time enrollment status for this myasthenia gravis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:51 PM UTC
| NCT Number | NCT06909214 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis |
| Phase | PHASE4 |
| Target Enrollment | 30 participants |
| Active Locations | 18 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | March 10, 2026 (Mar 10, 2026) |
As of July 17, 2026: Clinical trial NCT06909214 is currently recruiting participants. This phase4 study for myasthenia gravis is actively seeking new participants at 18 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06909214 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06909214 was last updated Mar 10, 2026 (March 10, 2026). HelloStudys verifies this status automatically.